Literature DB >> 21955038

Examining docking interactions on ERK2 with modular peptide substrates.

Sunbae Lee1, Mangalika Warthaka, Chunli Yan, Tamer S Kaoud, Pengyu Ren, Kevin N Dalby.   

Abstract

ERK2 primarily recognizes substrates through two recruitment sites, which lie outside the active site cleft of the kinase. These recruitment sites bind modular-docking sequences called docking sites and are potentially attractive sites for the development of non-ATP competitive inhibitors. The D-recruitment site (DRS) and the F-recruitment site (FRS) bind D-sites and F-sites, respectively. For example, peptides that target the FRS have been proposed to inhibit all ERK2 activity (Galanis, A., Yang, S. H., and Sharrocks, A. D. (2001) J. Biol. Chem. 276, 965-973); however, it has not been established whether this inhibition is steric or allosteric in origin. To facilitate inhibitor design and to examine potential coupling of recruitment sites to other ligand recognition sites within ERK2, energetic coupling within ERK2 was investigated using two new modular peptide substrates for ERK2. Modeling shows that one peptide (Sub-D) recognizes the DRS, while the other peptide (Sub-F) binds the FRS. A steady-state kinetic analysis reveals little evidence of thermodynamic linkage between the peptide substrate and ATP. Both peptides are phosphorylated through a random-order sequential mechanism with a k(cat)/K(m) comparable to Ets-1, a bona fide ERK2 substrate. Occupancy of the FRS with a peptide containing a modular docking sequence has no effect on the intrinsic ability of ERK2 to phosphorylate Sub-D. Occupancy of the DRS with a peptide containing a modular docking sequence has a slight effect (1.3 ± 0.1-fold increase in k(cat)) on the intrinsic ability of ERK2 to phosphorylate Sub-F. These data suggest that while docking interactions at the DRS and the FRS are energetically uncoupled, the DRS can exhibit weak communication to the active site. In addition, they suggest that peptides bound to the FRS inhibit the phosphorylation of protein substrates through a steric mechanism. The modeling and kinetic data suggest that the recruitment of ERK2 to cellular locations via its DRS may facilitate the formation of F-site selective ERK2 signaling complexes, while recruitment via the FRS will likely inhibit ERK2 through a steric mechanism of inhibition. Such recruitment may serve as an additional level of ERK2 regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955038      PMCID: PMC3422614          DOI: 10.1021/bi201103b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  Docking interactions induce exposure of activation loop in the MAP kinase ERK2.

Authors:  Tianjun Zhou; Liguang Sun; John Humphreys; Elizabeth J Goldsmith
Journal:  Structure       Date:  2006-06       Impact factor: 5.006

2.  Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3.

Authors:  Sijiu Liu; Jin-Peng Sun; Bo Zhou; Zhong-Yin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 3.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

Review 4.  Docking interactions in protein kinase and phosphatase networks.

Authors:  Attila Reményi; Matthew C Good; Wendell A Lim
Journal:  Curr Opin Struct Biol       Date:  2006-10-31       Impact factor: 6.809

Review 5.  Differential regulation and properties of MAPKs.

Authors:  M Raman; W Chen; M H Cobb
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

6.  Activated signal transduction kinases frequently occupy target genes.

Authors:  Dmitry K Pokholok; Julia Zeitlinger; Nancy M Hannett; David B Reynolds; Richard A Young
Journal:  Science       Date:  2006-07-28       Impact factor: 47.728

7.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

Authors:  M D Eldridge; C W Murray; T R Auton; G V Paolini; R P Mee
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

8.  Properties and regulation of a transiently assembled ERK2.Ets-1 signaling complex.

Authors:  Kari A Callaway; Mark A Rainey; Austen F Riggs; Olga Abramczyk; Kevin N Dalby
Journal:  Biochemistry       Date:  2006-11-21       Impact factor: 3.162

9.  Use of docking peptides to design modular substrates with high efficiency for mitogen-activated protein kinase extracellular signal-regulated kinase.

Authors:  Neychelle Fernandes; Denise E Bailey; David L Vanvranken; Nancy L Allbritton
Journal:  ACS Chem Biol       Date:  2007-10-06       Impact factor: 5.100

10.  Expanding the repertoire of an ERK2 recruitment site: cysteine footprinting identifies the D-recruitment site as a mediator of Ets-1 binding.

Authors:  Olga Abramczyk; Mark A Rainey; Richard Barnes; Lance Martin; Kevin N Dalby
Journal:  Biochemistry       Date:  2007-07-21       Impact factor: 3.162

View more
  18 in total

1.  In-situ generation of differential sensors that fingerprint kinases and the cellular response to their expression.

Authors:  Diana Zamora-Olivares; Tamer S Kaoud; Kevin N Dalby; Eric V Anslyn
Journal:  J Am Chem Soc       Date:  2013-09-18       Impact factor: 15.419

2.  Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma.

Authors:  Ashraf A Aly; Essmat M El-Sheref; Momtaz E M Bakheet; Mai A E Mourad; Stefan Bräse; Mahmoud A A Ibrahim; Martin Nieger; Boyan K Garvalov; Kevin N Dalby; Tamer S Kaoud
Journal:  Bioorg Chem       Date:  2018-10-23       Impact factor: 5.275

3.  Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors.

Authors:  Johannes Rudolph; Yao Xiao; Arthur Pardi; Natalie G Ahn
Journal:  Biochemistry       Date:  2014-12-04       Impact factor: 3.162

4.  Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine.

Authors:  Mangalika Warthaka; Charles H Adelmann; Tamer S Kaoud; Ramakrishna Edupuganti; Chunli Yan; William H Johnson; Scarlett Ferguson; Clint D Tavares; Lindy J Pence; Eric V Anslyn; Pengyu Ren; Kenneth Y Tsai; Kevin N Dalby
Journal:  ACS Med Chem Lett       Date:  2014-10-17       Impact factor: 4.345

5.  Mapping the binding interface of ERK and transcriptional repressor Capicua using photocrosslinking.

Authors:  Alan S Futran; Saw Kyin; Stanislav Y Shvartsman; A James Link
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 6.  Monomeric and dimeric models of ERK2 in conjunction with studies on cellular localization, nuclear translocation, and in vitro analysis.

Authors:  Sunbae Lee; Yun Soo Bae
Journal:  Mol Cells       Date:  2012-03-23       Impact factor: 5.034

7.  Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase.

Authors:  Haoling Qi; Sudhakaran Prabakaran; François-Xavier Cantrelle; Béatrice Chambraud; Jeremy Gunawardena; Guy Lippens; Isabelle Landrieu
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

8.  The Relationship between Effective Molarity and Affinity Governs Rate Enhancements in Tethered Kinase-Substrate Reactions.

Authors:  Elizabeth B Speltz; Jesse G Zalatan
Journal:  Biochemistry       Date:  2020-06-01       Impact factor: 3.162

9.  Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf.

Authors:  Ramin Samadani; Jun Zhang; Amanda Brophy; Taiji Oashi; U Deva Priyakumar; E Prabhu Raman; Franz J St John; Kwan-Young Jung; Steven Fletcher; Edwin Pozharski; Alexander D MacKerell; Paul Shapiro
Journal:  Biochem J       Date:  2015-05-01       Impact factor: 3.857

10.  A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.

Authors:  Seung-Keun Hong; Pui-Kei Wu; Jong-In Park
Journal:  Cell Signal       Date:  2017-10-03       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.